These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8989060)

  • 41. Effect of salmeterol on allergen-induced airway inflammation in mild allergic asthma.
    Boulet LP; Chakir J; Milot J; Boutet M; Laviolette M
    Clin Exp Allergy; 2001 Mar; 31(3):430-7. PubMed ID: 11260155
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Salmeterol does not alter increased bronchial responsiveness caused by organic dust exposure.
    Ek A; Palmberg L; Sundblad BM; Larsson K
    Chest; 2005 Oct; 128(4):3038-47. PubMed ID: 16236984
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Efficacy of salmeterol in patients with allergic bronchial asthma].
    Pacor ML; Biasi D; Cortina P; Maleknia T; Lunardi C
    Clin Ter; 1994 Aug; 145(8):131-4. PubMed ID: 7955958
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Additive bronchoprotective and bronchodilator effects with single doses of salmeterol and montelukast in asthmatic patients receiving inhaled corticosteroids.
    Dempsey OJ; Wilson AM; Sims EJ; Mistry C; Lipworth BJ
    Chest; 2000 Apr; 117(4):950-3. PubMed ID: 10767223
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Salmeterol: a novel, long-acting beta 2-agonist.
    Meyer JM; Wenzel CL; Kradjan WA
    Ann Pharmacother; 1993 Dec; 27(12):1478-87. PubMed ID: 7905757
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study.
    Wilding P; Clark M; Thompson Coon J; Lewis S; Rushton L; Bennett J; Oborne J; Cooper S; Tattersfield AE
    BMJ; 1997 May; 314(7092):1441-6. PubMed ID: 9167559
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is the result of methacholine challenge accurate for assessing the bronchoprotective effects of long-acting beta-adrenergic bronchodilators?
    Bumbacea D; Diot P; Lamarie E
    Chest; 1996 Jul; 110(1):305-6. PubMed ID: 8681658
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of an inhaled glucocorticosteroid on mast cell and smooth muscle beta 2 adrenergic tolerance in mild asthma.
    Yates DH; Worsdell M; Barnes PJ
    Thorax; 1998 Feb; 53(2):110-3. PubMed ID: 9624295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhaled salmeterol and albuterol in asthmatic patients receiving high-dose inhaled corticosteroids.
    Lai CK; Chan CH; Ho SS; Hui AC; Lai KN
    Chest; 1995 Jul; 108(1):36-40. PubMed ID: 7606988
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
    Cazzola M; Centanni S; Boveri B; Di Marco F; Santus P; Matera MG; Allegra L
    Respiration; 2001; 68(5):452-9. PubMed ID: 11694805
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjects.
    Gauvreau GM; Jordana M; Watson RM; Cockroft DW; O'Byrne PM
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1738-45. PubMed ID: 9412549
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol.
    Swystun VA; Gordon JR; Davis EB; Zhang X; Cockcroft DW
    J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):57-64. PubMed ID: 10887306
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol.
    Grove A; Lipworth BJ
    Thorax; 1996 Jun; 51(6):585-9. PubMed ID: 8693438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A 1-week dose-ranging study of inhaled salmeterol in patients with asthma.
    Bronsky EA; Kemp JP; Orgel HA; Bierman CW; Tinkelman DG; van As A; Liddle RF
    Chest; 1994 Apr; 105(4):1032-7. PubMed ID: 7909285
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The influence of polymorphism at position 16 of the beta2-adrenoceptor on the development of tolerance to beta-agonist.
    Taylor DR; Hancox RJ; McRae W; Cowan JO; Flannery EM; McLachlan CR; Herbison GP
    J Asthma; 2000 Dec; 37(8):691-700. PubMed ID: 11192234
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potential masking effects of salmeterol on airway inflammation in asthma.
    Mcivor RA; Pizzichini E; Turner MO; Hussack P; Hargreave FE; Sears MR
    Am J Respir Crit Care Med; 1998 Sep; 158(3):924-30. PubMed ID: 9731027
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in methacholine induced bronchoconstriction with the long acting beta 2 agonist salmeterol in mild to moderate asthmatic patients.
    Booth H; Fishwick K; Harkawat R; Devereux G; Hendrick DJ; Walters EH
    Thorax; 1993 Nov; 48(11):1121-4. PubMed ID: 8296255
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Salmeterol provides prolonged protection against exercise-induced bronchoconstriction in a majority of subjects with mild, stable asthma.
    Newnham DM; Ingram CG; Earnshaw J; Palmer JB; Dhillon DP
    Respir Med; 1993 Aug; 87(6):439-44. PubMed ID: 8105520
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol.
    Taylor DR; Town GI; Herbison GP; Boothman-Burrell D; Flannery EM; Hancox B; Harré E; Laubscher K; Linscott V; Ramsay CM; Richards G
    Thorax; 1998 Sep; 53(9):744-52. PubMed ID: 10319056
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Duration of protection by inhaled salmeterol in exercise-induced asthma.
    Anderson SD; Rodwell LT; Du Toit J; Young IH
    Chest; 1991 Nov; 100(5):1254-60. PubMed ID: 1682113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.